Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Biorxiv : the Preprint Server for Biology
|
July 19, 2024
RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness
Gnana P Krishnamoorthy, Anthony R Glover, Brian R Untch, et al.
Cancer Discovery
|
September 12, 2015
NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition
Maria E R Garcia-Rendueles, Julio C Ricarte-Filho, Brian R Untch, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 26, 2024
<i>RAS</i>-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance
Hannah J Sfreddo, Elizabeth S Koh, Karena Zhao, et al.
The Journal of Experimental Medicine
|
February 24, 2025
RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs
Gnana P Krishnamoorthy, Anthony R Glover, Brian R Untch, et al.
Surgery
|
October 10, 2025
Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumors
Aradhya Nigam, Michael A Mederos, Yagiz A Aksoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2021
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma
Bin Xu, Talia L Fuchs, Sara Ahmadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2025
Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors
Ciara M Kelly, Martina Bradic, Sara Saunds, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesis
Vera Tiedje, Pablo Sánchez Vela, Julie L Yang, et al.
Histopathology
|
January 22, 2024
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma
Yagiz A Aksoy, Bin Xu, Kartik Viswanathan, et al.
Nature Communications
|
June 15, 2022
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
Benjamin A Nacev, Francisco Sanchez-Vega, Shaleigh A Smith, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Biorxiv : the Preprint Server for Biology
|
July 19, 2024
RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness
Gnana P Krishnamoorthy, Anthony R Glover, Brian R Untch, et al.
Cancer Discovery
|
September 12, 2015
NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition
Maria E R Garcia-Rendueles, Julio C Ricarte-Filho, Brian R Untch, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 26, 2024
<i>RAS</i>-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance
Hannah J Sfreddo, Elizabeth S Koh, Karena Zhao, et al.
The Journal of Experimental Medicine
|
February 24, 2025
RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs
Gnana P Krishnamoorthy, Anthony R Glover, Brian R Untch, et al.
Surgery
|
October 10, 2025
Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumors
Aradhya Nigam, Michael A Mederos, Yagiz A Aksoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2021
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma
Bin Xu, Talia L Fuchs, Sara Ahmadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2025
Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors
Ciara M Kelly, Martina Bradic, Sara Saunds, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesis
Vera Tiedje, Pablo Sánchez Vela, Julie L Yang, et al.
Histopathology
|
January 22, 2024
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma
Yagiz A Aksoy, Bin Xu, Kartik Viswanathan, et al.
Nature Communications
|
June 15, 2022
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
Benjamin A Nacev, Francisco Sanchez-Vega, Shaleigh A Smith, et al.
Page
of 5